Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05255068 · ClinicalTrials.gov registry record · NA
OPTIMAL in NH Residents With Dementia
A NA study of Alzheimer's Disease and Related Dementias, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
- 1
- Study location
NCT05255068: Completed NA study of Alzheimer's Disease and Related Dementias, sponsored by University of Iowa.
NCT05255068 is a NA study of Alzheimer's Disease and Related Dementias that has completed, run by University of Iowa. The registered enrollment target is 111 participants, below the 1,617-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05255068, a NA study of Alzheimer's Disease and Related Dementias, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and refine OPTIMAL and evaluate its feasibility, fidelity, and usefulness. The OPTIMAL is designed to teach staff to effectively engage residents in eating using individualized, person-centered behavioral strategies.
Primary Outcome
All staff participants were interviewed on whether the intervention protocol and training materials were acceptable and appropriate for nursing home mealtime care practice before pilot testing.
Conditions Studied
Interventions
- BEHAVIORAL OPTIMAL
Study Locations (1)
Iowa
- Iowa Vateran's Home - Marshalltown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2022-11-05 |
| Phase | NA |
What the finished NCT05255068 record still lists
NCT05255068 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,617-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Alzheimer's Disease and Related Dementias appearing as the primary indexed condition, and to 1 intervention - of which OPTIMAL is the first listed.
NCT05255068 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT05255068 about?
NCT05255068 is a clinical study titled "OPTIMAL in NH Residents With Dementia". The purpose of this study is to develop and refine OPTIMAL and evaluate its feasibility, fidelity, and usefulness. The OPTIMAL is designed to teach staff to effectively engage residents in eating using individualized, person-centered behavioral strategies.
What is the current status of trial NCT05255068?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2022-05-16. Estimated completion is 2022-11-05.
What conditions does trial NCT05255068 study?
This clinical trial studies the following conditions: Alzheimer's Disease and Related Dementias.
What interventions are being tested in trial NCT05255068?
The interventions under investigation include: OPTIMAL (BEHAVIORAL).
Who is sponsoring clinical trial NCT05255068?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05255068 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer's Disease and Related Dementias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
RECRUITING · NA
-
Translating Data Science to Palliative Care
COMPLETED · NA
-
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
COMPLETED · NA
-
Smart Lighting for Nursing Home Residents With Dementia
COMPLETED · NA
-
Preventing Alzheimer's With Cognitive Training
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI